Sanico, Fe .
HRN: 27-17-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2025
CEFTRIAXONE 1G (VIAL)
05/27/2025
06/02/2025
IV
2g
OD
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes